The UK is ahead of Europe and the US and gives the green light to Pfizer’s vaccine
Pfizer’s vaccine will be available in UK next week
The UK has become the first Western country to approve a vaccine for Covid-19, with the pharmaceutical supervisor giving the green light to the vaccine from Pfizer and BioNTech. London is ahead of the EU and the United States in the emergency permit for the antidote, which is expected to be key to halting the global pandemic. The European and American authorities are currently processing the permission of the vaccine from Pfizer and BioNtech, analyzing the safety and efficacy of the trials carried out on tens of thousands of patients.
The vaccine will be available in Britain from next week, according to a statement from the UK government. London had already indicated that it would try to speed up the approval of the vaccine as much as possible to protect its population, and doctors are on hold for a possible deployment. The so-called Joint Committee on Vaccination and Immunization (JCVI) is expected to publish its recommendation on which groups will be the first to receive the vaccine, but it is expected that it will be the elderly and health personnel. The country has agreed to purchase 40 million doses of the drug (two are administered per person) to immunize 20 million citizens.
The Regulatory Agency for Medicines and Health has indicated that the vaccine “met the strict standards of safety, quality and efficacy” required. Pfizer, along with Moderna and AstraZeneca (associated with Oxfrod University), have been ahead in the race to deliver a coronavirus vaccine as soon as possible. Processes that usually take between five and 10 years have been advanced to less than one. In addition, China has licensed three different vaccines for emergency use, and Russia approved another one known as Sputnik V.
The British government, in late November, invoked a rule that allows the regulator to speed up approval processes. The news is a relief for the Government of Boris Johnson, harassed by its management of the pandemic, which has caused 60,000 deaths in the country, which faces the rebellion by its party over restrictive measures while trying to close a last-minute agreement with the EU for Brexit.
Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective Moderna Inc said it will request authorization for emergency use in Read more
Pfizer's coronavirus vaccine sparks optimism. The European Commission announced this Wednesday an agreement reached with the pharmaceutical firms Pfizer and Read more
Pfizer’s late-stage coronavirus vaccine trial is near complete. The countdown to the arrival of the Covid vaccine has begun. Pfizer Read more
45 vaccine candidates in human trials. Governments, companies, health systems and citizens scrutinize with great interest to know when a Read more
Moderna prepares for the "commercial launch" of its vaccine. Modern biotechnology begins the procedures to request the authorization of its Read more
Moderna claims its COVID-19 vaccine produces a "robust" immune response. Scientists around the world will continue to search for a Read more
US Quickly Seeks COVID-19 Vaccine. "Phase 1 of the clinical trial to evaluate an investigational vaccine designed for coronavirus disease Read more
Grifols starts the trial to test its immunoglobulin in patients with Covid-19. Grifols has announced the start of the clinical Read more
The European Union approves extraordinary funds of 750 billion for recovery after the pandemic. With a «We did it! Read more
CytoDyn rejected by the FDA. The FDA rejected CytoDyn’s application for its lead program, an antibody to treat HIV in Read more